Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–28.

Article  CAS  PubMed  Google Scholar 

Vest JR, Gamm LD, Oxford BA, et al. Determinants of preventable readmissions in the United States: a systematic review. Implement Sci. 2010;5:88.

Article  PubMed  PubMed Central  Google Scholar 

PCNE Classification for Drug-Related Problems V9.1. Pharmaceutical Care Network Europe Association; 2020. Available at: https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf. Accessed May 2020.

El Morabet N, Uitvlugt EB, van den Bemt BJF, et al. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66(3):602–8.

Article  PubMed  Google Scholar 

Graabæk T, Terkildsen BG, Lauritsen KE, et al. Frequency of undocumented medication discrepancies in discharge letters after hospitalization of older patients: a clinical record review study. Ther Adv Drug Saf. 2019;10:2042098619858049.

Article  PubMed  PubMed Central  Google Scholar 

Parekh N, Ali K, Stevenson JM, et al. Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK. Br J Clin Pharmacol. 2018;84(8):1789–97.

Article  PubMed  PubMed Central  Google Scholar 

Cooper JB, Jeter E, Sessoms CJ. Rates and types of medication-related problems in patients rehospitalized within 30 days of discharge from a community hospital. J Pharm Technol. 2020;36(2):47–53.

Article  PubMed  Google Scholar 

Dalleur O, Beeler PE, Schnipper JL, et al. 30-day potentially avoidable readmissions due to adverse drug events. J Patient Saf. 2021;17(5):e379–86.

Article  PubMed  Google Scholar 

Uitvlugt EB, Janssen MJA, Siegert CEH, et al. Medication-related hospital readmissions within 30 days of discharge: prevalence, preventability, type of medication errors and risk factors. Front Pharmacol. 2021;12: 567424.

Article  PubMed  PubMed Central  Google Scholar 

Whitaker AS, Cottrell WN. What proportion of unplanned re-presentations to an emergency department are medication related and preventable? J Pharm Pract Res. 2019;49(6):546–56.

Article  Google Scholar 

Linkens A, Milosevic V, van der Kuy PHM, et al. Medication-related hospital admissions and readmissions in older patients: an overview of literature. Int J Clin Pharm. 2020;42(5):1243–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schönenberger N, Blanc AL, Hug BL, et al. Developing indicators for medication-related readmissions based on a Delphi consensus study. Res Social Adm Pharm. 2024;20(6):92–101.

Article  PubMed  Google Scholar 

Kripalani S, Roumie CL, Dalal AK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1–10.

Article  PubMed  PubMed Central  Google Scholar 

Walker PC, Bernstein SJ, Jones JNT, et al. Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study. Arch Intern Med. 2009;169(21):2003–10.

Article  PubMed  Google Scholar 

Miller D, Ramsey M, L’Hommedieu TR, et al. Pharmacist-led transitions-of-care program reduces 30-day readmission rates for Medicare patients in a large health system. Am J Health Syst Pharm. 2020;77(12):972–8.

Article  PubMed  Google Scholar 

Kelly WN, Ho M-J, Bullers K, et al. Association of pharmacist counseling with adherence, 30-day readmission, and mortality: a systematic review and meta-analysis of randomized trials. J Am Pharm Assoc. 2021;61(3):340.

Article  Google Scholar 

Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2): e010003.

Article  PubMed  PubMed Central  Google Scholar 

March KL, Peters MJ, Finch CK, et al. Pharmacist transition-of-care services improve patient satisfaction and decrease hospital readmissions. J Pharm Pract. 2022;35(1):86–93.

Article  PubMed  Google Scholar 

Farley TM, Shelsky C, Powell S, et al. Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm. 2014;36(2):430–7.

Article  PubMed  PubMed Central  Google Scholar 

Al-Hashar A, Al-Zakwani I, Eriksson T, et al. Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use. Int J Clin Pharm. 2018;40(5):1154–64.

Article  PubMed  Google Scholar 

Odeh M, Scullin C, Fleming G, et al. Ensuring continuity of patient care across the healthcare interface: telephone follow-up post-hospitalization. Br J Clin Pharmacol. 2019;85(3):616–25.

Article  PubMed  PubMed Central  Google Scholar 

Witherington EMA, Pirzada OM, Avery AJ. Communication gaps and readmissions to hospital for patients aged 75 years and older: observational study. Qual Saf Health Care. 2008;17(1):71–5.

Article  CAS  PubMed  Google Scholar 

Bülow C, Clausen SS, Lundh A, et al. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2023;1(1):Cd008986.

PubMed  Google Scholar 

Daliri S, Boujarfi S, el Mokaddam A, et al. Medication-related interventions delivered both in hospital and following discharge: a systematic review and meta-analysis. BMJ Qual Saf. 2021;30(2):146–56.

Article  PubMed  Google Scholar 

Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894–900.

Article  PubMed  Google Scholar 

Ravn-Nielsen LV, Duckert M-L, Lund ML, et al. Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med. 2018;178(3):375–82.

Article  PubMed  PubMed Central  Google Scholar 

Gurwitz JH, Kapoor A, Garber L, et al. Effect of a multifaceted clinical pharmacist intervention on medication safety after hospitalization in persons prescribed high-risk medications: a randomized clinical trial. JAMA Intern Med. 2021;181(5):610–8.

Article  PubMed  PubMed Central  Google Scholar 

Kempen TGH, Bertilsson M, Hadziosmanovic N, et al. Effects of hospital-based comprehensive medication reviews including postdischarge follow-up on older patients’ use of health care: a cluster randomized clinical trial. JAMA Netw Open. 2021;4(4):e216303.

Article  PubMed  PubMed Central  Google Scholar 

Harris M, Moore V, Barnes M, et al. Effect of pharmacy-led interventions during care transitions on patient hospital readmission: a systematic review. J Am Pharm Assoc (2003). 2022;62(5):1477.

Article  PubMed  Google Scholar 

Rodrigues CR, Harrington AR, Murdock N, et al. Effect of pharmacy-supported transition-of-care interventions on 30-day readmissions: a systematic review and meta-analysis. Ann Pharmacother. 2017;51(10):866–89.

Article  PubMed  Google Scholar 

Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.

Article  PubMed  Google Scholar 

Lazaridis D, Partosh D, Ricabal LC, et al. Impact of a centralized population health pharmacy program on value-based Medicare patients 2003. J Am Pharm Assoc. 2024;64(1):146–53.

Article  Google Scholar 

Gallagher D, Greenland M, Lindquist D, et al. Inpatient pharmacists using a readmission risk model in supporting discharge medication reconciliation to reduce unplanned hospital readmissions: a quality improvement intervention. BMJ Open Qual. 2022;11(1):e001560.

Article  PubMed  PubMed Central  Google Scholar 

Fosnight S, King P, Ewald J, et al. Effects of pharmacy interventions at transitions of care on patient outcomes. Am J Health Syst Pharm. 2020;77(12):943–9.

Article  PubMed  Google Scholar